Application of NSAIDs in the treatment of pulmonary diseases- a comparative study of the therapeutic & the adverse impacts

Application of NSAIDs in the treatment of pulmonary diseases- a comparative study of the therapeutic & the adverse impacts

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2019.

Бібліографічні деталі
Автор:	Rahman, Farhana
Інші автори:	Afrose, Afrina
Формат:	Дисертація
Мова:	English
Опубліковано:	Brac University 2021
Предмети:	NSAIDs Pulmonary diseases Pulmonary administration Therapeutic effectiveness Adverse impacts Better & safe treatment opportunities Lungs > Diseases
Онлайн доступ:	http://hdl.handle.net/10361/14396

Схожі ресурси

Different approaches in the treatment of obstructive pulmonary diseases
за авторством: Kabir, Eva Rahman, та інші
Опубліковано: (2016)

Pulmonary patient compliance among different types of inhaler dosage forms in Mohakhali, Dhaka
за авторством: Rithin, Rafia Islam
Опубліковано: (2022)

Patients' compliance in pulmonary drug delivery systems in Mirpur
за авторством: Faruqe, Abdullah Al
Опубліковано: (2021)

Prevalence and risk factors of chronic obstructive pulmonary disease in Bangladesh: A systematic review
за авторством: Sutradhar, Ipsita, та інші
Опубліковано: (2022)

A case study of lung cancer patients in term of various risk factors in context of Bangladesh
за авторством: Shabnam, Musharrat
Опубліковано: (2018)

Evaluation of three immunological tests for the diagnosis of pulmonary tuberculosis in a rural endemic area of Bangladesh
за авторством: Islam, Mohammad Tariqul, та інші
Опубліковано: (2016)

Occupational Pulmonary Tuberculosis among BRAC Community Health Workers of Trishal, Bangladesh
за авторством: Karim, Fazlul, та інші
Опубліковано: (2019)

Therapeutic and adverse effects of SSRIs
за авторством: Rahman, Imtiazur
Опубліковано: (2018)

Lost in care pathway: a qualitative investigation on the health system delay of extra pulmonary tuberculosis patients in Bangladesh
за авторством: Sarker, Malabika, та інші
Опубліковано: (2018)

A short review on additional therapeutic effects and adverse effects of sedative and hypnotic drugs
за авторством: Tisha, Sadia Sultana
Опубліковано: (2021)

A brief survey on the effect of smoke of different sources on COPD patients
за авторством: Nawal, Nusrat
Опубліковано: (2021)

Investigation of adverse effects of oral voriconazole in the treatment of fungal infection using The FDA Adverse Event Reporting System (FAERS)
за авторством: Onanna, Kazi
Опубліковано: (2024)

Prevalence of Tuberculosis and associated factors in Sylhet, Bangladesh
за авторством: Ara, Effat
Опубліковано: (2021)

The adverse impact on the project by facade package
за авторством: BUCG
Опубліковано: (2023)

Barriers to oral and inhaled drug delivery: a review
за авторством: Kamal, Farhana
Опубліковано: (2023)

An overview on Covid-19 and invention of its treatment by drugs
за авторством: Nawer, Anika
Опубліковано: (2022)

Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer
за авторством: Rahman, Tasnim
Опубліковано: (2024)

Role of protein’s and future treatment options for Alzheimer’s Disease
за авторством: Islam, Md. Irfath
Опубліковано: (2023)

Potential of liposomes for the treatment of lung cancer- a review
за авторством: Mim, Shanzida
Опубліковано: (2023)

A review on recent advances in drugs for lung cancer treatment
за авторством: Noor, Fouzia
Опубліковано: (2024)

Parkinson’s disease and COVID-19: treatment and patient management during a pandemic
за авторством: Afsana, Nourin
Опубліковано: (2022)

Treatment regimens of urinary bladder adenocarcinoma
за авторством: Tarafder, Ayndrila
Опубліковано: (2024)

A review on the pathophysiology and potential drugs for Covid-19
за авторством: Modak, Srijani
Опубліковано: (2022)

Use of nano-emulsion for delivery of NSAID
за авторством: Khatun, Hafiza
Опубліковано: (2021)

Treatment options of Parkinson’s disease: How far we are from the cure?
за авторством: Afreen, Nuraia
Опубліковано: (2021)

A comprehensive review on drug repurposing in cancer treatment
за авторством: Sarkar, Onusree
Опубліковано: (2024)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
за авторством: Flora, Sanzida Alam
Опубліковано: (2024)

Implications of unusual non-coding RNAs in human diseases
за авторством: Ahmed, Tazkia
Опубліковано: (2021)

Exploring the potential of organic molecules in the treatment of covid-19
за авторством: Mondol, Winifred Claire
Опубліковано: (2024)

Stem cells as therapeutic carrier in cancer treatment
за авторством: Anika, Mysha Yeasmin
Опубліковано: (2022)

A review on targeted therapies for lung cancer
за авторством: Ashraf, Anushey
Опубліковано: (2023)

Antimicrobial peptides in skin diseases
за авторством: Pinkey, Monika Tabassum
Опубліковано: (2022)

Biologics and Biosimilars as Treatment Options for Psoriasis
за авторством: Moya, Amena Khatun
Опубліковано: (2023)

Medications used for covid-19 treatment and a comparison of their mechanism of action and therapeutic efficacy
за авторством: Sultana, Sadia
Опубліковано: (2023)

Vitamin C and the common cold /
за авторством: Pauling, Linus, 1901-1994
Опубліковано: (1970)

Evaluation of wound healing using a combination therapy of NSAID and an antioxidant on mice model
за авторством: Biswas, Raisa Prapti
Опубліковано: (2018)

Tuberculosis associates with both airflow obstruction and low lung function: BOLD results
за авторством: F. S. Amaral, André, та інші
Опубліковано: (2017)

Evaluation of endometriosis risk factors, symptoms, and clinical treatments in Bangladesh: a cross-sectional study
за авторством: Afrose, Afsana
Опубліковано: (2024)

PCSK9i: proprotein convertase subtilisin/kexin type 9 inhibitor a new phase of lipid-lowering treatment
за авторством: Lubaba, Anikah
Опубліковано: (2024)

Antimicrobial peptides in the treatment of dermatosis
за авторством: Hussain, Sumaya Binty
Опубліковано: (2024)